BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Ipsogen 

Bât A, 2 bd Luce

Marseille    13008  France
Phone: 33-0-4-91-29-30-90 Fax: 33-0-4-91-29-30-99


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals





 Company News
TrovaGene, Inc., Achieves Intellectual Property Milestone Under License Agreement with Ipsogen 8/29/2012 10:00:34 AM    More...
QIAGEN N.V. (QGEN) Reaches Agreement To Buy 61% Stake In Ipsogen, Plans To Fully Acquire Leader In Oncology Molecular Diagnostics 7/11/2011 6:19:21 AM    More...
QIAGEN Inc. (QGEN) Plans to Buy Cancer MDx Firm Ipsogen for $101 Million 6/15/2011 9:30:06 AM    More...
The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer 1/11/2010 8:44:30 AM    More...
Ipsogen Reports Incorporation of the Genomic Grade in the 2009 St. Gallen International Consensus Meeting 7/10/2009 8:39:12 AM    More...
Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic Assays 5/4/2009 7:08:56 AM    More...
Ipsogen Announces the CE Marking of its "ProfileQuant(R) WT1" Kit 3/16/2009 7:43:56 AM    More...
Ipsogen Reinforces its Leadership in Molecular Diagnosis and Monitoring of Leukemia 1/12/2009 10:45:04 AM    More...
Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer 11/24/2008 8:33:39 AM    More...
Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer 11/24/2008 6:39:59 AM    More...
123

//-->